Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Rectal Cancer treatment details. Chemotherapy. Kyoto University Graduate School of Medicine, Kyoto, Japan

Survival: 17.6 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Xeloda
Country: Japan
City/State/Province: Kyoto
Hospital: Kyoto University Graduate School of Medicine
Journal: Link
Date: 2/2004

Patients: This phase II study involved 56 patients with advanced/metastatic colorectal cancer.

Treatment: Treatment consisted of the chemotherapy drug, capecitabine (xeloda).

Toxicity: The most common grade 3/4 laboratory abnormalities were lymphocytopenia and hyperbilirubinemia. Other toxicities included: hand-foot syndrome, anorexia, diarrhea, and fever.

Results: Median overall survival was 17.6 months.

Support: Nippon Roche KK provided the study drug and supported the study. Roche markets capecitabine.

Correspondence: J. Sakamoto

E-mail to a Friend Email Physician More Information